(Q46490967)

22 December 2017

title

Immunosuppressive activity of proteases in cervical carcinoma (English)

1 reference

22 December 2017

author

Adrian Daneri-Navarro

1

1 reference

22 December 2017

author name string

Susana Del Toro-Arreola

2

1 reference

22 December 2017

Pedro Ernesto Sanchez-Hernandez

3

1 reference

22 December 2017

Maria Guadalupe Ramirez-Dueñas

4

1 reference

22 December 2017

J Armendariz-Borunda

5

1 reference

22 December 2017

Ruy Perez-Montfort

6

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

22 December 2017

published in

Gynecologic Oncology

1 reference

22 December 2017

volume

98

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

111-117

1 reference

22 December 2017

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

1 reference

Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Chapter 5: Viral and host factors in human papillomavirus persistence and progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Immune evasion in human papillomavirus-associated cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Transforming growth factor-β1 induces tumor stroma and reduces tumor infiltrate in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Identification and characterisation of a group of cervical carcinoma patients with profound downregulation of intratumoral Type 1 (IFNgamma) and Type 2 (IL-4) cytokine mRNA expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Fas ligand expression in cervical adenocarcinoma: relevance to lymph node metastasis and tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Down-Regulation of CD25 Expression on the Surface of Activated Tumor-Infiltrating Lymphocytes in Human Cervical Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Human and mouse proteases: a comparative genomic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Proteases, extracellular matrix, and cancer: a workshop of the path B study section

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Clinical, cellular, and molecular aspects of cancer invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Proteolytic activity in extracts of invasive cervical carcinoma and precursor lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Urokinase-type plasminogen activator and plasminogen activator inhibitors (PAI-1 and PAI-2) in extracts of invasive cervical carcinoma and precursor lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Escape from immunotherapy: possible mechanisms that influence tumor regression/progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Immunoregulatory T cells in tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Correlates of IL-10 and IL-12 concentrations in cervical secretions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Proteolysis of monocyte CD14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Altered levels of urokinase on monocytes and in serum of children with AIDS; effects on lymphocyte activation and surface marker expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.034

10.1016/J.YGYNO.2005.03.034

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017